Does ENZALUTAMIDE Cause Hyperhidrosis? 560 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 560 reports of Hyperhidrosis have been filed in association with ENZALUTAMIDE (Xtandi). This represents 1.1% of all adverse event reports for ENZALUTAMIDE.
560
Reports of Hyperhidrosis with ENZALUTAMIDE
1.1%
of all ENZALUTAMIDE reports
25
Deaths
72
Hospitalizations
How Dangerous Is Hyperhidrosis From ENZALUTAMIDE?
Of the 560 reports, 25 (4.5%) resulted in death, 72 (12.9%) required hospitalization, and 1 (0.2%) were considered life-threatening.
Is Hyperhidrosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENZALUTAMIDE. However, 560 reports have been filed with the FAERS database.
What Other Side Effects Does ENZALUTAMIDE Cause?
Fatigue (8,891)
Death (6,680)
Malignant neoplasm progression (4,696)
Prostatic specific antigen increased (3,731)
Asthenia (3,589)
Drug ineffective (3,468)
Hot flush (3,144)
Decreased appetite (3,069)
Nausea (2,898)
Dizziness (2,776)
What Other Drugs Cause Hyperhidrosis?
DULOXETINE (4,101)
ADALIMUMAB (2,745)
SODIUM (2,444)
VENLAFAXINE (1,932)
LEVOTHYROXINE (1,856)
ACETAMINOPHEN (1,578)
ETANERCEPT (1,521)
MORPHINE (1,438)
GABAPENTIN (1,408)
PREGABALIN (1,385)
Which ENZALUTAMIDE Alternatives Have Lower Hyperhidrosis Risk?
ENZALUTAMIDE vs EPCORITAMAB
ENZALUTAMIDE vs EPCORITAMAB-BYSP
ENZALUTAMIDE vs EPERISONE
ENZALUTAMIDE vs EPHEDRINE
ENZALUTAMIDE vs EPINASTINE